【慢速VOA】２００８－０３－１８

【士兵突击==三多123号】

Report Points to Limits of Some Antidepressants (1/2)

A study has raised new questions about effectiveness of several popular drugs for depression. These antidepressions are known as selective * * *serotonin reuptake inhibitors.SSRIs are designed to help keep *serotonin, a brain chemical,at a continuous level. ~~But~~ the new study suggests that they provide little help to the large majority of the millions who take them. Scientists from Britain,Canadia and the United States did the study. It was a ~~mata~~ mate-analysis, a study of studies. The team used an American law, the Freedom of Information Act,to get unpublished reports on thirty-five clinical trials of 4 drugs. Drug companies give these un and published studies to the Food and Drug Administration for a approval of the medicines. In a the clinical trails ,people with depression were treated with either antidepressant or a *placebo. A pill that contains no medicine. They did not know which they got. The new report says those who received medicine did improved. But comparable numbers of those who received * placebo also improved. The report says the drugs had meaningful results only in the most servely depressed patients.

我的译文：
一项研究对几种流行的抗抑郁症药提出质疑。这些抗抑郁症药被认为是选择性复合胺---大脑中的一种化学成份再吸收的抑制剂。SSIRs正在计划保持复合胺水平恒定。一项新的研究表明这些抗抑郁药几乎对百万服用他们的病人没有作用。来自英国，加拿大，美国的研究脑功能的科学家们做了此项研究。这是荟萃分析，基于许多研究的一项研究。此团队使用美国的《信息自由法案》，获得了未曝光的4种药品的35个临床实验报告。医药公司提供了这些报告而且把研究成果出版，以使得食品药品监管局正式批准这些药物的生产。在临床试验报告中，抑郁症患者或者服用抗抑郁症药，或者服用安慰剂（一种没有真正药物的片剂）。而患者不知道他们服用的是哪一种。新的研究表明服用药品的患者确实好转，但是服用安慰剂的患者同样也好转了。报告认为药品只对那些得严重抑郁症的患者有意义。

单词总结：
serotonin
n.含于血液中的复合胺
reuptake
n. (神经细胞对化学物质的)再吸收,再摄取
inhibitors
n. [化]抑制剂, 抑制者
placebo
n.为死者所诵的晚祷词, 安慰剂